Health Care & Life Sciences » Pharmaceuticals | FluoroPharma Medical Inc.

FluoroPharma Medical Inc.

FluoroPharma Medical Inc.
Stock Exchange Other OTC
Market Cap
$616.72 K
Shares Outstanding
34.26 M
Public Float
33.52 M


8 Hillside Avenue
Montclair New Jersey 07042
United States
Employees -
Updated 07/08/2019
FluoroPharma Medical, Inc. engages in the research, development, and commercialization molecular imaging pharmaceuticals with initial applications in the area of cardiology. It focuses on the development of breakthrough positron emission tomography imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ.


View All

Walter W. Witoshkin
Thomas H. Tulip
President, Chief Executive Officer & Director